Which of the following antihistaminic is free of arrhythmogenic potential?
**Core Concept**
The question is testing the arrhythmogenic potential of different antihistaminic agents. Antihistamines can have varying effects on the heart, ranging from prolongation of the QT interval to induction of torsades de pointes. This is due to their ability to block potassium channels, which can lead to prolongation of the action potential duration and increased susceptibility to arrhythmias.
**Why the Correct Answer is Right**
Fexofenadine is a second-generation antihistamine that is free of arrhythmogenic potential. This is because it primarily exerts its antihistaminic effects through selective blockade of peripheral H1 receptors, without significant effects on cardiac potassium channels. Unlike other antihistamines, fexofenadine does not significantly prolong the QT interval or increase the risk of torsades de pointes.
**Why Each Wrong Option is Incorrect**
**Option A:** Diphenhydramine has a high risk of arrhythmogenic potential due to its ability to block cardiac potassium channels, which can lead to QT interval prolongation and increased risk of torsades de pointes.
**Option B:** Cetirizine also has some risk of arrhythmogenic potential, although it is less pronounced than other second-generation antihistamines. However, it can still prolong the QT interval to a lesser extent.
**Option C:** Loratadine is another second-generation antihistamine that has some risk of arrhythmogenic potential, although it is generally considered to be safer than first-generation antihistamines like diphenhydramine. However, it can still prolong the QT interval to a lesser extent.
**Clinical Pearl / High-Yield Fact**
When choosing an antihistamine, it is essential to consider the patient's cardiovascular risk factors, as some antihistamines can increase the risk of arrhythmias. Fexofenadine is a good option for patients with a history of cardiac arrhythmias or those taking medications that can prolong the QT interval.
**Correct Answer:** C. Fexofenadine is free of arrhythmogenic potential.